Barclays Cuts Cigna Outlook, Highlights PBM Transition Risk
Barclays shifted its view on The Cigna Group, trimming expectations and flagging execution risks, while UBS offered a brighter take after a stronger quarter; this article unpacks the analyst moves, the business structure at play, the core risks around the PBM shift, and the near-term data points investors should watch. On May 26, Barclays downgraded...